Milestone Scientific reports Q1 EPS (1c), consensus (1c)

Reports Q1 revenue $2.16M, consensus $2.5M. “Our first quarter results reflect continued progress as we execute on the foundation established in 2025,” said Eric Hines, CEO of Milestone Scientific (MLSS). “We delivered meaningful improvements in operating efficiency, reducing expenses by more than 30% and significantly narrowing our operating loss, while maintaining a relatively stable revenue base in a dynamic market environment, though revenue was impacted by challenges shipping certain booked orders to the Middle East due to the ongoing conflict in the region. Importantly, our medical business continued to gain traction, with revenue more than doubling year-over-year, reflecting early-stage adoption of our technology and growing interest from clinicians.”